Differences in MS patients' cerebrospinal fluid may be key to drugs that halt progression

Effective therapies exist for managing relapsing/remitting MS, but treatment for progressive MS has proved more challenging. Now, a new article has identified potential mechanisms that may inform the development of therapies that effectively manage progressive MS.